Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis ; volume:18 ; number:1 ; day:28 ; month:8 ; year:2019 ; pages:1-13 ; date:12.2019
Cardiovascular diabetology ; 18, Heft 1 (28.8.2019), 1-13, 12.2019
- Creator
-
Fei, Yue
Tsoi, Man-Fung
Cheung, Bernard Man Yung
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-019-0916-z
- URN
-
urn:nbn:de:101:1-2020011021180968503669
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fei, Yue
- Tsoi, Man-Fung
- Cheung, Bernard Man Yung
- SpringerLink (Online service)
Other Objects (12)
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials
Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Updates on cardiovascular outcome trials in diabetes
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials
Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Updates on cardiovascular outcome trials in diabetes
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials
Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Updates on cardiovascular outcome trials in diabetes
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials